Director of Spanish National Cancer Research Centre.
Maria A. Blasco obtained her PhD in 1993 at the Centro de Biología Molecular "Severo Ochoa" under the supervision of M. Salas. That same year, Blasco joined the Cold Spring Harbor Laboratory in New York (USA) as a Postdoctoral Fellow under the leadership of C. W. Greider. As a postdoc she isolated one of the telomerase essential genes and generated the first telomerase deficient mouse model, which served to demonstrate the importance of telomerase in telomere maintenance, chromosomal instability and disease. In 1997, she returned to Spain to start her own research Group at the Centro Nacional de Biotecnología in Madrid. She joined the Spanish National Cancer Research Centre (CNIO) in 2003 as Director of the Molecular Oncology Programme and Leader of the Telomeres and Telomerase Group. In 2005, she was also appointed Vice-Director of Basic Research at CNIO. Since June 2011, she is the CNIO Director.
Visit website: https://www.cnio.es/en/personas/maria-a-blasco-2/
See also: Spanish National Cancer Research Center (CNIO) - Center for cancer research, including diagnosis and treatments.
Maria Blasco is also referenced in the following:
Feature length documentary about longevity and radical life extension with due to be released in 2023
Longevity Leaders World Congress 2022
26-Feb-2022 to 27-Feb-2022
Event for leaders in longevity science, technology, business and finance organized by Longevity Leaders (LSX)
Longevity Summit Dublin 2022
18-Sep-2022 to 20-Sep-2022
Event gathering Global Longevity and Rejuvenation community in Dublin with many longevity movement superstars as speakers
Maria Blasco News
Rapamycin decreased survival and longevity in mice with short telomeres
Phys.org - 03-Mar-2020
mTOR, a pro-survival pathway for shorter telomeres and inhibition is deleteriousRead more...
Pluripotency and telomeres, butterfly effect discovered
ScienceDaily - 20-Aug-2019
Pluripotent cells are like a black box, but they can open new doors for regenerative medicineRead more...
Telomerase therapy for neurodegeneration
Lifespan.io (LEAF) - 04-Jun-2019
Telomerase gene therapy may be a potential solution for age-related neurodegenerative diseasesRead more...
Telomerase Gene Therapy Does Not Increase Cancer Risk
Lifespan.io (LEAF) - 27-Aug-2018
New research proves telomerase therapy's safety by making its effects within the cell temporaryRead more...